Sittner & Nelson’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$199K Hold
43,000
0.07% 167
2025
Q4
$221K Buy
43,000
+10,000
+30% +$52.1K 0.08% 156
2025
Q3
$167K Hold
33,000
0.06% 159
2025
Q2
$142K Hold
33,000
0.06% 168
2025
Q1
$199K Buy
+33,000
New +$167K 0.08% 141
2024
Q4
Sell
-40,000
Closed -$234K 498
2024
Q3
$234K Buy
+40,000
New +$197K 0.1% 122
2023
Q4
Sell
-375
Closed -$2.04K 478
2023
Q3
$2.04K Hold
375
﹤0.01% 422
2023
Q2
$3.47K Sell
375
-20,186
-98% -$171K ﹤0.01% 427
2023
Q1
$169K Buy
20,561
+9
+0% +$99 0.1% 126
2022
Q4
$229K Buy
20,552
+7,510
+58% +$87.3K 0.14% 109
2022
Q3
$155K Buy
13,042
+6,006
+85% +$91K 0.1% 119
2022
Q2
$107K Buy
7,036
+1,000
+17% +$18K 0.07% 139
2022
Q1
$128K Buy
6,036
+36
+0.6% +$776 0.07% 129
2021
Q4
$142K Buy
6,000
+3,000
+100% +$64.3K 0.08% 122
2021
Q3
$60K Buy
+3,000
New +$61.5K 0.04% 174

Other funds holding MPT

Sittner & Nelson's MPT Position: Q1 2026 in Review

Sittner & Nelson held its Medical Properties Trust (MPT) position steady in Q1 2026 at 43,000 shares worth $199K. The position accounts for 0.07% of the portfolio, ranked #167.

Sittner & Nelson first reported a position in MPT in Q3 2021 and has held it in 15 quarters since. The position peaked at $234K in Q3 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Sittner & Nelson held 43,000 shares of Medical Properties Trust worth $199K as of Q1 2026.
  • Sittner & Nelson left its Medical Properties Trust share count unchanged in Q1 2026.
  • Medical Properties Trust made up 0.07% of Sittner & Nelson's portfolio in Q1 2026, its #167 holding.
  • Sittner & Nelson first reported a position in Medical Properties Trust in Q3 2021 and has held it in 15 quarters since.
  • Sittner & Nelson's Medical Properties Trust position peaked at $234K in Q3 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.